A truncated anti-PSMA aptamer (A10-3.2) was used as a prostate cancer cell-specific ligand for microRNA-loaded polyamidoamine (PAMAM) dendrimer delivery (Wu et al., 2011). Here, FOLH1 is linked to prostate cancer.